Biogen (BIIB)

Biogen jumped 2.4% in the premarket after reporting an
adjusted profit of $5.25 per share for the second quarter, beating the
consensus estimate of $4.06. Revenue also exceeded analysts’ forecasts. The
strong results came even as Biogen said it faces increasing generic and
biosimilar competition for its Tecfidera and Rituxan drugs.

Also Read | Population density analytics thread goes viral on Twitter. See Elon Musk’s reaction

Baker Hughes (BKR)

Shares of the oilfield services company tumbled 6% in
premarket action after it reported second-quarter adjusted earnings of 11 cents
per share, just half of what analysts had anticipated. Revenue also fell short
of estimates, with Baker Hughes citing various challenges including component
shortages and supply chain inflation.

Also Read | US primaries: Maryland voters set House Democrats vs GOP clash for midterms

Merck (MRK)

Merck declined 1.5% in the premarket after its Keytruda
cancer drug failed to meet its goal in a late-stage study focused on head and
neck cancer patients.

Also Read | European Union’s gas supply could keep dwindling, Russia’s Vladimir Putin warns

Netflix (NFLX)

Netflix surged 6.1% in premarket action after reporting
subscriber losses that were substantially below expectations. The streaming
services said it would add a net 1 million new subscribers this quarter.
Netflix posted better-than-expected quarterly earnings, though revenue fell
marginally below Wall Street estimates.

Also Read | Ukraine must win the war before winter, says Volomymyr Zelensky aide

ASML (ASML)

ASL slid 1.04% in premarket trading after the Netherlands-based
semiconductor manufacturing equipment maker cut its full-year sales forecast.
ASML posted better-than-expected quarterly earnings but said its customers are
turning somewhat cautious in anticipation of slowing chip demand.

Also Read | China extends loans for developers to end mortgage boycott

Cal-Maine Foods (CALM)

Cal-Maine added 1% in premarket trading after reporting
robust top and bottom line growth for its latest quarter. The nation’s largest
egg producer was supported by higher egg prices but also witnessed feed costs
that it expects to continue in fiscal 2023.

Also Read | Respect for Marriage Act: 47 Republicans who voted to protect same-sex marriage

Elevance Health (ELV)

Shares of the health care and insurance company fell 2.90%
after beating top and bottom line second-quarter estimates and raising its
full-year forecast. Elevance’s profits came on the back of a strong performance
in its pharmacy benefits management unit.

Also Read | Respect for Marriage Act’s legislative passage in US: Explained

Casino Stocks

Shares of casino operators rose in premarket trading
following a Reuters report that Macau would reopen casinos on Saturday amid a
decline in Covid infections. Las Vegas Sands (LVS) added 1.5% while Wynn
Resorts (WYNN) gained 1.9%.